Karius
Karius Raises $100M in Series C Financing Round
The funding round was co-led by Khosla Ventures and new investors 5AM Ventures and Gilde Healthcare.
In Brief This Week: Quest Diagnostics; T2 Biosystems; OraSure Technologies; DermTech; and More
News items for the week of July 31, 2023.
Karius Taps Capstone Health Alliance to Broaden Patient Access to Infectious Disease Testing
Doctors at Capstone member hospitals will be able to more easily order the Karius Test for patients harboring hard-to-diagnose infections.
Karius Receives NY State Approval for Infectious Disease Liquid Biopsy Test
The permit covers the test for all five pathogen categories: bacteriology, mycobacteriology, mycology, parasitology, and virology.
The liquid biopsy test compares fragments of cfDNA to a reference database of more than 1,400 microbial pathogens to determine infection.
Feb 24, 2020
Karius Raises $165M in Series B Financing Round
Nov 29, 2018
Karius Secures $25M Loan
Oct 8, 2018